Search Results Search Sort by RelevanceMost Recent Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210. Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609. In the Literature Aug 2009 The Belmont Report's Misleading Conception of Autonomy Sigurdur Kristinsson, PhD Virtual Mentor. 2009;611-616. doi: 10.1001/virtualmentor.2009.11.8.jdsc1-0908. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Aug 2001 My Doctor the Researcher Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(8):259-260. doi: 10.1001/virtualmentor.2001.3.8.hlaw1-0108. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Next page Next › Last page Last »
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
In the Literature Oct 2002 Should Clinician-Researchers Disclose Financial Incentives to Patients? Jeremy Spevick Virtual Mentor. 2002;4(10):299-301. doi: 10.1001/virtualmentor.2002.4.10.jdsc1-0210.
Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609.
In the Literature Aug 2009 The Belmont Report's Misleading Conception of Autonomy Sigurdur Kristinsson, PhD Virtual Mentor. 2009;611-616. doi: 10.1001/virtualmentor.2009.11.8.jdsc1-0908.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2002;4(10):288-291. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
Case and Commentary Oct 2002 Clinician and Researcher, Commentary 2 Matthew Wynia, MD, MPH Virtual Mentor. 2002;4(10):292-295. doi: 10.1001/virtualmentor.2002.4.10.ccas1-0210.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Aug 2001 My Doctor the Researcher Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(8):259-260. doi: 10.1001/virtualmentor.2001.3.8.hlaw1-0108.